Product NDC: | 0024-5831 |
Proprietary Name: | Auvi-Q |
Non Proprietary Name: | epinephrine |
Active Ingredient(s): | .15 mg/1 & nbsp; epinephrine |
Administration Route(s): | INTRAMUSCULAR; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-5831 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA201739 |
Marketing Category: | NDA |
Start Marketing Date: | 20121115 |
Package NDC: | 0024-5831-02 |
Package Description: | 2 INJECTION in 1 CARTON (0024-5831-02) |
NDC Code | 0024-5831-02 |
Proprietary Name | Auvi-Q |
Package Description | 2 INJECTION in 1 CARTON (0024-5831-02) |
Product NDC | 0024-5831 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | epinephrine |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; SUBCUTANEOUS |
Start Marketing Date | 20121115 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | EPINEPHRINE |
Strength Number | .15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |